Diagnosis of reported beta-lactam hypersensitivity in different diagnostic risk groups
Rattachement africain : pl. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Introduction: Beta-lactam (BL) antibiotics are one of the most common causes of drug hypersensitivity.Diagnosis of hypersensitivity to BL antibiotics includes: skin prick tests (SPT), intradermal tests (IDT), drug provocation tests (DPT) and allergen-specific IgE (sIgE) determination.Diagnostic methods of BL hypersensitivity remain the same for years.Aim: The aim of our study was to analyze the relevance of diagnostic methods in patients with reported BL allergy in different diagnostic risk groups. Material and methods:The database included a detailed medical history, laboratory test results and allergy work-up.263 patients were included in the study.The low-risk group consisted of 88 (33.46%) patients, moderate of 129 (49.05%) patients and 46 (17.49%) patients were classified to the high diagnostic risk group.Results: Diagnostic risk groups of hypersensitivity to BL antibiotics do not differ in laboratory results, including a specific IgE level.In 23 (8.7%) patients, hypersensitivity to BL antibiotics was confirmed regardless of the risk group.Among the patients with positive skin tests (10/263, 3.8%) or provocation test (13/263, 4.9%), 6 (2.3%) patients were diagnosed with hypersensitivity to the BL ring, 2 (0.76%) with cross-sensitivity between aminopenicillin, and amino-cephalosporin, 3 (1.14%)were diagnosed with hypersensitivity to two BL antibiotics from different groups, 12 (4.5%)had confirmed hypersensitivity to the reported BL antibiotic, including 6 (2.3%) diagnosed with IgE-independent hypersensitivity to the reported BL antibiotic.Conclusions: Diagnostic risk groups of hypersensitivity to BL antibiotics do not differ in laboratory results.Skin tests are useful in diagnosing hypersensitivity to BL antibiotics, but DPT remain the gold standard.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Diagnosis of reported beta-lactam hypersensitivity in different diagnostic risk groups
- Date Crossref
- 01/01/2025
- Éditeur
- Termedia Sp. z.o.o.
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Medical University of Silesia Department of Internal Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Allergology and Clinical Immunology Department of Internal Medicine pays non établi dans la noticeÉtablissement de santé
Department of Internal Medicine — Medical University of Silesia et Department of Internal Medicine — Allergology and Clinical Immunology.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.